BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36826062)

  • 1. Five-Fraction Stereotactic Radiotherapy for Brain Metastases-A Retrospective Analysis.
    Layer JP; Layer K; Sarria GR; Röhner F; Dejonckheere CS; Friker LL; Zeyen T; Koch D; Scafa D; Leitzen C; Köksal M; Schmeel FC; Schäfer N; Landsberg J; Hölzel M; Herrlinger U; Schneider M; Giordano FA; Schmeel LC
    Curr Oncol; 2023 Jan; 30(2):1300-1313. PubMed ID: 36826062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of linac-based fractionated stereotactic radiotherapy and stereotactic radiosurgery for patients with up to ten brain metastases.
    Hirata M; Yasui K; Oota N; Ogawa H; Onoe T; Maki S; Ito Y; Hayashi K; Asakura H; Murayama S; Mitsuya K; Deguchi S; Nakamura K; Hayashi N; Nishimura T; Harada H
    Radiat Oncol; 2022 Dec; 17(1):213. PubMed ID: 36578021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
    Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
    J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic radiosurgery and fractionated stereotactic radiotherapy: comparison of efficacy and toxicity in 260 patients with brain metastases.
    Fokas E; Henzel M; Surber G; Kleinert G; Hamm K; Engenhart-Cabillic R
    J Neurooncol; 2012 Aug; 109(1):91-8. PubMed ID: 22528795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of adjuvant fractionated stereotactic radiotherapy dose on local control of brain metastases.
    Musunuru HB; Witt JS; Yadav P; Francis DM; Kuczmarska-Haas A; Labby ZE; Bassetti MF; Howard SP; Baschnagel AM
    J Neurooncol; 2019 Nov; 145(2):385-390. PubMed ID: 31606876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment Outcomes After Higher-dose Fractionated Stereotactic Radiotherapy (FSRT) Alone for 1-4 Brain Metastases.
    Johannwerner L; Werner EM; Janssen S; Yu NY; Rades D
    Anticancer Res; 2023 Jun; 43(6):2757-2762. PubMed ID: 37247897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fractionated stereotactic radiotherapy to the post-operative cavity for radioresistant and radiosensitive brain metastases.
    Ahmed KA; Freilich JM; Abuodeh Y; Figura N; Patel N; Sarangkasiri S; Chinnaiyan P; Yu HH; Etame AB; Rao NG
    J Neurooncol; 2014 May; 118(1):179-86. PubMed ID: 24604750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation Necrosis Following Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy with High Biologically Effective Doses for Large Brain Metastases.
    Johannwerner L; Werner EM; Blanck O; Janssen S; Cremers F; Yu NY; Rades D
    Biology (Basel); 2023 Apr; 12(5):. PubMed ID: 37237469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effectiveness of multi-fraction stereotactic radiosurgery for surgically resected or intact large brain metastases from non-small-cell lung cancer (NSCLC).
    Minniti G; Scaringi C; Lanzetta G; Anzellini D; Bianciardi F; Tolu B; Morace R; Romano A; Osti M; Gentile P; Paolini S
    Lung Cancer; 2019 Jun; 132():119-125. PubMed ID: 31097084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-fraction versus hypofractionated stereotactic radiosurgery for medium-sized brain metastases of 2.5 to 3 cm.
    Chon H; Yoon K; Lee D; Kwon DH; Cho YH
    J Neurooncol; 2019 Oct; 145(1):49-56. PubMed ID: 31420793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fractionated pre-operative stereotactic radiotherapy for patients with brain metastases: a multi-institutional analysis.
    Palmer JD; Perlow HK; Matsui JK; Ho C; Prasad RN; Liu K; Upadhyay R; Klamer B; Wang J; Damante M; Ghose J; Blakaj DM; Beyer S; Grecula J; Arnett A; Thomas E; Chakravarti A; Lonser R; Hardesty D; Prevedello D; Prabhu R; Elder JB; Raval RR
    J Neurooncol; 2022 Sep; 159(2):389-395. PubMed ID: 35751740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local progression and pseudo progression after single fraction or fractionated stereotactic radiotherapy for large brain metastases. A single centre study.
    Wiggenraad R; Verbeek-de Kanter A; Mast M; Molenaar R; Kal HB; Lycklama à Nijeholt G; Vecht C; Struikmans H
    Strahlenther Onkol; 2012 Aug; 188(8):696-701. PubMed ID: 22722818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-dose versus fractionated stereotactic radiotherapy for brain metastases.
    Kim YJ; Cho KH; Kim JY; Lim YK; Min HS; Lee SH; Kim HJ; Gwak HS; Yoo H; Lee SH
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):483-9. PubMed ID: 20800386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic Cavity Irradiation or Whole-Brain Radiotherapy Following Brain Metastases Resection-Outcome, Prognostic Factors, and Recurrence Patterns.
    El Shafie RA; Dresel T; Weber D; Schmitt D; Lang K; König L; Höne S; Forster T; von Nettelbladt B; Eichkorn T; Adeberg S; Debus J; Rieken S; Bernhardt D
    Front Oncol; 2020; 10():693. PubMed ID: 32477942
    [No Abstract]   [Full Text] [Related]  

  • 15. Single-fraction radiosurgery versus fractionated stereotactic radiotherapy in patients with brain metastases: a comparative study.
    Loo M; Pin Y; Thierry A; Clavier JB
    Clin Exp Metastasis; 2020 Jun; 37(3):425-434. PubMed ID: 32185576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative hypofractionated stereotactic brain radiation (HSRT) for resected brain metastases: improved local control with higher BED
    Kumar AMS; Miller J; Hoffer SA; Mansur DB; Coffey M; Lo SS; Sloan AE; Machtay M
    J Neurooncol; 2018 Sep; 139(2):449-454. PubMed ID: 29749569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fractionated stereotactic radiotherapy of brain metastases from renal cell carcinoma.
    Ikushima H; Tokuuye K; Sumi M; Kagami Y; Murayama S; Ikeda H; Tanaka M; Oyama H; Shibui S; Nomura K
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1389-93. PubMed ID: 11121638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fractionated stereotactic radiotherapy of intracranial postoperative cavities after resection of brain metastases - Clinical outcome and prognostic factors.
    Hahnemann L; Krämer A; Fink C; Jungk C; Thomas M; Christopoulos P; Lischalk JW; Meis J; Hörner-Rieber J; Eichkorn T; Deng M; Lang K; Paul A; Meixner E; Weykamp F; Debus J; König L
    Clin Transl Radiat Oncol; 2024 May; 46():100782. PubMed ID: 38694237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome assessment of intraoperative radiotherapy for brain metastases: results of a prospective observational study with comparative matched-pair analysis.
    Layer JP; Hamed M; Potthoff AL; Dejonckheere CS; Layer K; Sarria GR; Scafa D; Koch D; Köksal M; Kugel F; Grimmer M; Holz JA; Zeyen T; Friker LL; Borger V; Schmeel FC; Weller J; Hölzel M; Schäfer N; Garbe S; Forstbauer H; Giordano FA; Herrlinger U; Vatter H; Schneider M; Schmeel LC
    J Neurooncol; 2023 Aug; 164(1):107-116. PubMed ID: 37477822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of radionecrosis in single-fraction radiosurgery compared with fractionated radiotherapy in the treatment of brain metastasis.
    Donovan EK; Parpia S; Greenspoon JN
    Curr Oncol; 2019 Jun; 26(3):e328-e333. PubMed ID: 31285676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.